share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MCKENZIE DIANA

SEC announcement ·  May 4 04:23
Summary by Futu AI
On May 1, 2024, Diana McKenzie, associated with Vertex Pharmaceuticals Inc. (VRTX), engaged in transactions involving the company's common stock. McKenzie acquired 1,001 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, McKenzie's direct holdings in Vertex Pharmaceuticals totaled 2,436 shares. Additionally, it was reported that McKenzie holds 207 shares indirectly through a trust. The transactions have been marked as completed.
On May 1, 2024, Diana McKenzie, associated with Vertex Pharmaceuticals Inc. (VRTX), engaged in transactions involving the company's common stock. McKenzie acquired 1,001 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, McKenzie's direct holdings in Vertex Pharmaceuticals totaled 2,436 shares. Additionally, it was reported that McKenzie holds 207 shares indirectly through a trust. The transactions have been marked as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.